Notice for tixagevimab and cilgavimab (EVUSHELD) (AstraZeneca Pty Ltd)
Active ingredients
tixagevimab and cilgavimab (EVUSHELD)
Sponsor
Date of review outcome
Lapse date
Type
Provisional determination
Indication
For the prophylaxis of COVID-19 in adults 18 years of age and older.